The age of onset varies, but GAD is more common in adolescents and older children than in young children. In addition, affected adolescents and older children tend to have more symptoms than do affected younger children.
Prognosis
The prognosis is thought to be relatively good when treatment is implemented early and effectively. However, 35% of children one day develop a new psychiatric disorder in the same interval.
Children with GAD are also likely to meet criteria for other anxiety disorders and, to a lesser degree, for a depressive or disruptive behavior disorder.
Anxiety is a serious problem in children and adolescents. We now understand that, in addition to deleteriously affecting the child's social and academic functioning, anxiety can cause serious long-term consequences. Many children with one of the anxiety disorders suffer intermittently for the rest of their lives. Other serious psychiatric conditions, such as major depressive disorder and substance misuse, are closely associated with pediatric anxiety if not treated in a timely and effective manner.
GAD also may co-occur with conditions associated with stress, such as irritable bowel syndrome and headaches. The long-term physiologic effects of stress are more likely to cause non-psychiatric gastrointestinal, cardiovascular, or other consequences later in life.
History
Children with GAD may experience somatic symptoms such as shortness of breath, rapid heartbeat, sweating, nausea or diarrhea, frequent urination, cold and clammy hands, dry mouth, trouble swallowing, or a "lump in the throat." Problems with muscle tension also can occur, including trembling, twitching, a shaky feeling, and muscle soreness or aches. Patients often complain of stomachaches and headaches. Despite these symptoms, few findings are noted on a doctor's physical examination.
An evaluation for GAD should include data gathering through diagnostic interviews with the child and parent, direct observation, and questionnaires. Family history of anxiety and mood disorders, the child's early temperament and adjustment to school, and life stressors or disruptions are among important factors to consider in GAD.
The DSM-IV guidelines require the following to satisfy a diagnosis of GAD:
 Excessive anxiety and worry, occurring more days than not for at least 6 months, about a number of events or activities  Difficulty controlling the worry  One of the following symptoms in association with the worry: restlessness, fatigue, poor concentration, irritability, muscle tension, or sleep disturbance  Focus of worry that is not confined to features of another Axis I diagnosis, eg, worry about having a panic attack, social embarrassment, or separation from caregiver  Clinically significant distress or impairment experienced in social, school, or other important areas  Disturbance that is not due to a substance or general medical condition and that does not occur exclusively during a mood disorder, a psychotic disorder, or in association with a pervasive developmental disorder Common cognitive distortions in childhood GAD include:  Overestimation of the likelihood of dangerous events and catastrophic conclusions about the outcome (e.g. "If the sky gets dark, there will be a tornado, we'll lose our house, and I'll never be with my parents again")  High perception of threat and low perception of control (e.g. "I know if a dog comes near me, it will bite me.")  Overgeneralization of small errors to complete failure and subsequent loss of self-esteem ("If I make an error on this worksheet, that proves I'm stupid.")
Diagnostic Considerations
Substance-induced anxiety disorder, anxiety disorder due to a general medical condition, an adjustment disorder, or psychotic disorder will also be considered by the physician.
Distinguishing anxiety from developmentally appropriate fears is important. Throughout childhood and early adolescence, children experience various transitory fears occurring concurrently with their ability to recognize and understand potential dangers in their environment. A progression occurs from immediate, tangible fears (eg, separation from caregiver, strangers) to anticipatory, less tangible fears (eg, bad dreams, getting hurt, school failure). Children are expected to overcome and resolve these fears as part of the developmental process.
Distinguishing anxiety from realistic worry is also imperative. Worry can be thought of as a feeling of unease or concern about something. It represents an internal representation of a realistic threat. For example, a child with a learning disability may worry about an upcoming examination, or a child with a medical condition may worry about an upcoming surgery. This kind of worry is expected to be specific to a situation, and it is expected to subside once the situation has passed. Thus, the temporal requirement for GAD diagnosis (6 months) is not met.
Other conditions your child's physician will consider in the evaluation for GAD include the following: 
Behavioral and Cognitive-Behavioral Therapy
Weekly outpatient therapy for 3-4 months with less frequent follow-up booster sessions may be sufficient.
A cognitive-behavioral approach is likely to be most beneficial. Treatment should consist of individual sessions with family involvement to support the treatment process.
Behavioral and cognitive-behavioral therapies are among the most researched and promising treatments for childhood anxieties. Behavioral techniques (eg, relaxation training, modeling, imagining and visualizing, in vivo exposure) and cognitive techniques (eg, identifying and modifying self-talk, challenging irrational beliefs) often are used in combination with psychoeducation and contingency maintenance. Typically, children are taught to recognize early physiologic and cognitive signs of anxiety and to develop and implement coping techniques.
The importance of parental participation in the treatment process recently has received attention. Adding a family component focused on techniques such as contingency management, communication, and problem solving to individual child cognitive-behavioral therapy has produced favorable long-term treatment benefits in several clinical trials. 
Exercise, Caffeine Avoidance, Preoperative Relaxation Therapy
Regular exercise promotes a sense of well-being that is particularly beneficial in individuals with anxiety and mood disorders.
Limiting caffeine intake is appropriate.
Prior to a surgical procedure, children with an anxiety disorder are particularly likely to benefit from ageappropriate preparation, including relaxation practice for elective procedures.
Deterrence and Prevention
The following measures may aid in the prevention of GAD in children:
 Consistent, stable, supportive home environment  Parenting practices that promote self-confidence, self-esteem, and effective coping skills  Minimal number of psychosocial stressors or traumatic events  Adaptive problem solving and coping skills modeled by parents and other significant people in the child's life  Psychoeducation  Family-based interventions
Referrals
Early referral to a psychologist, psychiatrist, or behavioral-developmental pediatrician for evaluation and treatment can alleviate symptoms and stress that may be the early manifestations of a more severe disorder.
Family therapy referral also may be indicated, but that may be best managed by the mental health professional or the developmental and behavioral pediatrician who performs the consultative evaluation.
Medication Summary
Medication is ideally adjunctive (i.e. not the first therapy) to psychological treatment of generalized anxiety disorder (GAD). Unfortunately, the lack of experienced and qualified therapists in a community may preclude an adequate trial of cognitive-behavioral therapy.
Selective serotonin reuptake inhibitor (SSRI) antidepressants are currently first-line medications in the pharmacotherapy of anxiety disorders in children. These antidepressants are powerful anxiolytics with a broader spectrum that may improve comorbid affective disorders and symptoms of anxiety.
Benzodiazepines have a relatively favorable adverse effect profile but are generally not chosen as firstline treatments for anxiety in children and adolescents. These agents may cause behavioral disinhibition in young children. They also have street value as drugs of abuse.
Antihistamines and antipsychotics are not recommended for treatment of childhood-onset anxiety disorders.
